Bionano Genomics (BNGO) Asset Utilization Ratio (2018 - 2026)

Bionano Genomics (BNGO) has 9 years of Asset Utilization Ratio data on file, last reported at 0.42 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 13.14% year-over-year to 0.42; the trailing twelve-month figure through Mar 2026 stood at 0.42 (up 13.14% YoY), and the FY2025 full-year result was 0.38, up 79.45% from the prior year.
• Asset Utilization Ratio rose to 0.42 in Q1 2026, from 0.37 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.42 in Q1 2026 to a low of 0.06 in Q1 2022.
• A 5-year average of 0.23 and a median of 0.2 in 2024 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio jumped 127.63% in 2024 and decreased 0.46% in 2025, its largest moves.
• Tracing BNGO's Asset Utilization Ratio over 5 years: stood at 0.09 in 2022, then soared by 106.9% to 0.18 in 2023, then surged by 105.88% to 0.38 in 2024, then declined by 0.46% to 0.37 in 2025, then grew by 11.19% to 0.42 in 2026.
• Business Quant data shows BNGO's Asset Utilization Ratio at 0.42 in Q1 2026, 0.37 in Q4 2025, and 0.37 in Q3 2025.